Advisor Group Holdings, Inc. Elevation Oncology, Inc. Transaction History
Advisor Group Holdings, Inc.
- $67.1 Billion
- Q3 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,000 shares of ELEV stock, worth $720. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$720
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ELEV
# of Institutions
6Shares Held
2.84MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.49MShares$896,4890.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL174KShares$62,6890.0% of portfolio
-
Cibc Private Wealth Group, LLC161KShares$57,7900.0% of portfolio
-
Fny Investment Advisers, LLC10KShares$3,6000.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $8.39M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...